Trade Guardant Health, Inc. - GH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.77 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 45.03 |
| Open | 45.54 |
| 1-Year Change | 150.63% |
| Day's Range | 44.55 - 46.57 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 15, 2025 | 44.55 | -0.15 | -0.34% | 44.70 | 46.61 | 44.39 |
| Apr 14, 2025 | 45.03 | 0.74 | 1.67% | 44.29 | 45.71 | 43.67 |
| Apr 11, 2025 | 43.47 | 2.42 | 5.90% | 41.05 | 43.87 | 39.51 |
| Apr 10, 2025 | 41.07 | -0.72 | -1.72% | 41.79 | 42.36 | 39.12 |
| Apr 9, 2025 | 43.46 | 5.38 | 14.13% | 38.08 | 44.99 | 38.08 |
| Apr 8, 2025 | 39.73 | -3.45 | -7.99% | 43.18 | 44.43 | 38.90 |
| Apr 7, 2025 | 41.71 | 4.06 | 10.78% | 37.65 | 42.94 | 37.00 |
| Apr 4, 2025 | 40.52 | 1.20 | 3.05% | 39.32 | 42.01 | 38.92 |
| Apr 3, 2025 | 41.98 | 2.67 | 6.79% | 39.31 | 42.34 | 39.31 |
| Apr 2, 2025 | 43.24 | 1.97 | 4.77% | 41.27 | 43.97 | 40.85 |
| Apr 1, 2025 | 42.18 | 0.07 | 0.17% | 42.11 | 43.02 | 41.21 |
| Mar 31, 2025 | 42.49 | 1.06 | 2.56% | 41.43 | 43.19 | 40.67 |
| Mar 28, 2025 | 43.05 | -1.85 | -4.12% | 44.90 | 45.46 | 42.51 |
| Mar 27, 2025 | 45.10 | -0.02 | -0.04% | 45.12 | 46.78 | 44.02 |
| Mar 26, 2025 | 45.58 | 0.21 | 0.46% | 45.37 | 47.48 | 45.30 |
| Mar 25, 2025 | 46.19 | -0.71 | -1.51% | 46.90 | 47.42 | 45.75 |
| Mar 24, 2025 | 46.42 | 0.22 | 0.48% | 46.20 | 47.62 | 45.66 |
| Mar 21, 2025 | 45.77 | 2.49 | 5.75% | 43.28 | 46.29 | 43.16 |
| Mar 20, 2025 | 44.63 | -0.33 | -0.73% | 44.96 | 46.55 | 44.42 |
| Mar 19, 2025 | 46.16 | 2.57 | 5.90% | 43.59 | 46.72 | 42.52 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Guardant Health Company profile
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.| Industry: | Bio Diagnostics & Testing |
3100 Hanover Street
PALO ALTO
CALIFORNIA 94304
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com